《Drugs Of The Future》重点专注发布医学-药学领域的新研究，旨在促进和传播该领域相关的新技术和新知识。鼓励该领域研究者详细地发表他们的高质量实验研究和理论结果。该杂志创刊至今，在医学-药学领域，有较高影响力，对来稿文章质量要求较高，稿件投稿过审难度较大。欢迎广大同领域研究者投稿该杂志。
| CiteScore | SJR | SNIP | CiteScore排名 | |||
|---|---|---|---|---|---|---|
| 0.3 | 0.15 | 0.058 | 学科类别 | 分区 | 排名 | 百分位 |
|
大类：大类：Medicine
小类：小类：Pharmacology(medical)
|
Q4 | 247/272 | 9% | |||
|
大类：大类：Medicine
小类：小类：Pharmacology
|
Q4 | 287/313 | 8% | |||
| 按JIF指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
|---|---|---|---|---|
| 学科：PHARMACOLOGY & PHARMACY | SCIE | Q4 | 275 / 277 | 0.9% |
文章名称
引用次数
Rimegepant Calcitonin gene-related peptide (CGRP) receptor antagonist Treatment of migraine
3
Lemborexant Dual orexin receptor antagonist Treatment of insomnia
3
Amisulpride for the prevention and treatment of postoperative nausea and vomiting: A quantitative systematic review (meta-analysis)
2
Reltecimod T-cell-specific surface glycoprotein CD28 (TP44) antagonist CD28 homodimer interface mimetic peptide Treatment of necrotizing soft-tissue infection
2
Prolyl hydroxylase inhibitors for the treatment of anemia in chronic kidney disease
1
Brolucizumab Anti-VEGF-A monoclonal antibody Treatment of age-related macular degeneration
1
Vobarilizumab Anti-interleukin-6 receptor subunit alpha (CD126; IL-6R) Treatment of rheumatoid arthritis Treatment of systemic lupus erythematosus
1
Telaglenastat Glutaminase inhibitor Treatment of advanced solid tumors
1
Anifrolumab Anti-interferon-alpha receptor 1(IFNAR1) monoclonal antibody Treatment of systemic lupus erythematosus
1
Vilaprisan Progesterone receptor modulator Treatment of uterine fibroids
1
国家/地区
发文量
TSpain
124
TUSA
55
TEngland
48
TIndia
21
TItaly
15
TGERMANY (FED REP GER)
4
TCHINA MAINLAND
3
TAustralia
2
TCanada
2
TCzech Republic
2
